Position in BMY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$221,224,999
+$28,120,285 QoQ
Shares Held
3,647,568
+1.9% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58.477319682593986.ToString("F0")%
Shared 0.ToString("F0")%
None 41.52268031740601.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $4,442,669,348 across 18 Drug Manufacturers - General names. BMY ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,358,698 | $1,249,689,659 | |
| 2 | JNJ |
Johnson & Johnson
|
3,829,150 | $935,997,426 | |
| 3 | ABBV |
AbbVie Inc.
|
2,897,983 | $630,282,322 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,797,430 | $456,792,854 | |
| 5 | AMGN |
Amgen Inc
|
914,016 | $321,596,529 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,236,312 | $311,674,803 | |
| 7 | PFE |
Pfizer Inc
|
8,875,485 | $249,223,618 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
3,647,568 | $221,224,999 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $221,224,999 | 3,647,568 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $193,104,714 | 3,579,991 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $165,280,991 | 3,664,767 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $175,600,605 | 3,793,489 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $216,328,053 | 3,546,943 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $206,683,475 | 3,654,234 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $190,683,061 | 3,685,409 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $158,652,116 | 3,820,181 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $204,626,004 | 3,773,299 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $193,525,413 | 3,771,690 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $228,905,987 | 3,943,935 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $254,165,757 | 3,974,445 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $271,762,014 | 3,920,964 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $278,672,279 | 3,873,138 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $263,545,629 | 3,707,211 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $278,128,389 | 3,612,057 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $257,304,189 | 3,523,267 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $221,882,700 | 3,558,664 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $207,681,848 | 3,509,918 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $243,862,931 | 3,649,550 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $244,476,227 | 3,872,584 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $249,611,449 | 4,024,044 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $243,954,381 | 4,046,349 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $238,484,685 | 4,055,862 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $221,222,751 | 3,968,833 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||